Stay updated with breaking news from Heart Transplantation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the first randomized trial comparing approaches, transplantation of hearts donated after circulatory death resulted in similar 6-month recipient survival as hearts donated after brain death.
InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01 - read this article along with other careers information, tips and advice on BioSpace
GuruFocus Article or News written by Stock market mentor and the topic is about:
Calgary, Alberta--(Newsfile Corp. - January 19, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has received a $250,000 Letter of Commitment
Calgary, Alberta--(Newsfile Corp. - October 26, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce Dr. Giannetti and Dr. Cecere as Co-Lead